HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
RecruitingNCT06195553

Effectiveness of STEPPS Program in Borderline Personality Disorder

The registry lists this study as recruiting. Study locations are listed in Spain. Confirm recruitment at each site. It is testing STEPPS Program for Borderline Personality Disorder.

Personality disorders, Borderline personalityBehavioralOver 18 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Castellon, SpainSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 2, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
Universitat Jaume I
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
Spain
Age range
Over 18 Years
Official registry ID
NCT06195553
Official title
Application and Analysis of the Effectiveness of the STEPPS Program in Patients with BPD, Extending to Their Families with the Family Connections Program: a Randomized Controlled Trial

Want help reviewing this study?

Loading the security check...
Study ID: NCT06195553. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Castellon

Checked Official study record (opens in a new tab)
Registry details
Registry conditions (original wording)

Borderline Personality Disorder (BPD)

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Universitat Jaume I.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Drug study icon
RecruitingEUCTR 2022-003670-22

Controlled and randomized clinical trial to evaluate the efficacy of the combination of oxytocin plus self-compassion training in patients with Borderline Personality Disorder Ensayo clínico controlado y aleatorizado para evaluar la eficacia de la combinación de oxitocina más entrenamiento en autocompasión en pacientes con Trastorno Límite de Personalidad

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.